Friday, 15 December 2017

Reinventing Energy Drinks with Medium Chain Triglycerides (MCT) Oil

Medium-chain Triglycerides (MCTs) are fats present in foods such as palm kernel oil or coconut oil. Triglyceride, commonly known as fats, are either transported into cells and used for energy or are accumulated as body fat.MCTs are metabolized in a way that is different from Long-Chain Triglycerides (LCTs), whichare present in most other foods. Most fats in normal diets consist of long-chain fatty acids that contain 13 to 21 carbon atoms. Fats with short-chain fatty acids contain less than 6 carbons. However, medium-chain fatty acids in MCTs contain 6 to 12 carbons.

Due to the shorter chain length of MCTs, they are rapidly broken down and are absorbed easily into the body. These factors makethem a fast source of energy and less likely to be accumulated as fats. A diet with high MCTs could alsohelp with weight loss through increased fullness, lowered calorie intake, enhanced calorie burning, and less fat storage. Thus, MCTs have also become a popular supplement among bodybuilders and athletes.

MCT’s Newfound Application in Functional/Health Beverages

MCT oil has gained popularity in the food and beverage sectoracross the globe. While some companies are selling MCT oil as a separate product to be mixed with various beverages, other companies are using it in their ready-to-drink products. For instance, Each SKU in Metabrew’s nut-buttered, dairy-free teaand coffee range has 5 gmof MCT oil per 11 oz of drinks. Unlike other butter coffees that have a lot of calories and fats, these drinks contain relatively low calories and are brewed to fit more easily into customers’normal diet.

Market Overview

According to a report by Grand View Research, Inc., the global medium chain triglycerides (MCT) market is projected to witnessrapid growth during the forecast period (from 2016 to 2025), amountingto USD 2.46 billion by 2025. Increasing popularity of MCT oil among health-conscious people due to its ability to burn fats, provide energy, and improve metabolism is projected to steer the worldwide market. Moreover, rising demand for MCT products in the cosmetics industry is likely to boost the market.

Lonza Group Ltd.; BASF SE, Jarrow Formulas, Inc.; Barlean’s Organic Oils, LLC; NOW Foods; and Wilmar International Ltd. are some of the key companies operating in the global medium chain triglycerides (MCT) market.

To get free sample report at:

Wednesday, 13 December 2017

Increasing Use of Biological Approach in Integrated Pest Management

Climate changes are leading to increase in pest population, which in turn is resulting in food insecurity and various health problems. This is, thereby, raising the inclination toward integrated pest management (IPM). Primarily used for controlling and preventing the onslaught of insects, IPM is an effective and systematic approach using a combination of various prevention methods. An IPM program is designed on the basis of pest type, location or area, population density, and prevention goals.

Demand for Integrated Pest Management to Remain High in Agriculture Sector

Chemical, physical, biological, and mechanical are key approaches adopted in an integrated pest management program. Chemical is the most widely used approach, owing to easy availability of pesticides. However, rising awareness regarding harmful effects of pesticides and stringent government regulations pertaining to their sale and usage are likely to translate into reduced demand for the chemical approach. 

On the other hand, the biological segment is expected to register remarkable growth over the coming years. The approach involves release of a number of natural enemies into crop fields to control weeds, nematodes, vertebrates, plant pathogens, and invertebrates. For instance, potato and tomato growers across Hawke’s Bay and Canterbury, New Zealand, have started using Tamarixia trioaze, a wasp that destroys the tomato potato psyllid pest. The approach received approval from the Environmental Protection Authority in June 2016 and is anticipated to be commercialized on a large scale across New Zealand in the next six months.

Market Insights

The global integrated pest management market is largely driven by rising concerns pertaining to usage of pesticides. This can be coupled with favorable initiatives by governments promoting the adoption of IPM. Increasing focus on addressing issues such as food insecurity is also poised to drive the market. North America will hold a prominent position in the global arena, owing to growing investments in new product development.

Some of the key players in the market are BASF SE, Bayer CropScience LP, Advanced Integrated Pest Management, MB Integrated Pest Control, and IPM Technologies Pty Ltd.

To get free sample report at:

Sunday, 10 December 2017

Gas Chromatography-MS Systems to be a Breakthrough in Quantitative Testing

Gas chromatography (GC) is a process used in determining volatile substances in a gaseous state. It uses various techniques such as sample introduction, detection and analysis, and separation. Carrier gases such as helium, hydrogen, argon, and nitrogen are used on account of their compatibility with various detectors and other GC equipment.

Some GC applications are forensic testing, drug testing, food testing, beverage testing, and development of vaccines. Recently, the Fiji police department purchased a GC device to expand the investigational capability of their forensics laboratory. Major end users include healthcare, environmental agencies, and contract research organizations (CROs). GC is being increasingly used with mass spectrometry (MS) to calculate the mass of various compounds across samples. Development of these devices can reduce analysis time and increase efficiency.

Application in Multiple Sectors

Malaria was responsible for the death of more than 400,000 people globally in 2015, according to a survey by the World Health Organization (WHO). Researchers from the Swedish Royal Institute of Technology, Durham University, London School of Hygiene and Tropical Medicine, and the International Centre of Insect Physiology and Ecology (ICIPE) have collaborated to study and accurately identify the cause of malaria. They used GC and MS together to identify cedrol as the key component that attracts mosquitoes to breed in a particular place.

The pharmaceutical sector uses GC to identify harmful compounds in end products and raw materials. It was recently used to pinpoint the presence of anti-anxiety and anti-seizure drugs in fish. The GC-MS systems of Perkin Elmer were successfully used in pinpointing the quantities of compounds in drugs and vaccines.

Market Insights

The global gas chromatography market is anticipated to exceed a valuation of USD 4 billion by 2025, according to a report published by Grand View Research, Inc. Technological advances in GC are expected to augment market growth over the forecast period (2014-2025). Instruments and devices that can reduce analysis time are expected to drive market demand. Increase in government investments to encourage the adoption of GC across various industries is also anticipated to impact market volumes. 

Prominent market players include Bio-Rad Laboratories, Inc.; Danaher Corporation; Thermo Fisher Scientific, Inc.; and GE Healthcare.

Read more at:

Friday, 8 December 2017

Enteric Disease Testing to Alleviate Mortality among Humans

Increasing presence of pathogens in the air and rising number of casualties have increased the requirement of timely enteric disease testing in humans. Enteric diseases, resulting in symptoms such as nausea, diarrhea, and vomiting, generally happen due to consumption of contaminated food or water. Such diseases are highly communicable and timely testing can help doctors diagnose the accurate problem and provide early treatment. 

Rising Strategic Initiatives from Healthcare Organizations

Generally, there are three different types of enteric diseases: bacterial, viral, and parasitic. In 2016, enteric diseases caused by bacteria dominated the market. Salmonella, C. difficile, Shigella, E. coli, and Campylobacter are few bacteria that can cause enteric diseases. Increasing dependency on fast food and insufficient health awareness among humans is giving rise to bacterial infections. According to World Health Organization (WHO), around 1,72,454 people across the world get infected by cholera, resulting in high mortality rate. To handle the situation, various institutes and organizations in healthcare are taking strategic initiatives by promoting timely testing for such infections through healthcare camps and improving vaccines. For instance, a team of researchers at the University of Buffalo in New York is developing a new vaccine that will eradicate maximum bacteria strains causing pneumonia. Current versions of the vaccine can eradicate only 23 forms of Streptococcus pneumonia, including sepsis and meningitis. This advanced vaccine, on the other hand, can handle 72 forms of bacteria out of 90. 

Market Insights

Growing number of molecular diagnostic centers and advanced diagnostic technologies are expected to boost the global enteric disease testing market. In addition, rising dependency of humans on unhygienic fast food and increasing cases of mortality due to enteric infections can augment market growth. Frequent strategic initiatives taken by various healthcare organizations are likely to help the market reach a value of USD 4.2 billion by 2025, states Grand View Research Inc. in a recent report.

Some of the prominent players in the market are Alere Inc.; Quest Diagnostics; Bio Rad Laboratories; Becton Dickinson and Company; and Cepheid.

To get free sample request at:

Wednesday, 6 December 2017

Imaging Chemicals Prove Beneficial for Medical and Mining Sectors

Growing prevalence of major health issues and rapid acceptance of advanced technologies is gradually increasing the demand for imaging chemicals. In addition, increasing use of organic pigments by companies manufacturing such imaging chemicals is boosting its demand. Using these high-performance chemicals in the imaging process can enhance image clarity. Hence, they are majorly being used in the medical industry for detection and diagnosis of various health issues. Imaging chemicals are also in demand in the mining industry owing to their gradual adoption in various mineral exploration activities. Most mining exploration projects follow satellite and aerial imaging to obtain accurate location of railway tracks, roads, and inhabited areas. 

Varied Uses of Imaging Agents and Developers

Major product-variants of imaging chemicals are imaging agents and developers. Both are attracting considerable demand from various industries. However, imaging agents have been dominating the overall market. Continuous product developments, high R&D investments, and increasing demand in the medical industry can further propel the demand for imaging agents. These agents are capable of producing high-quality images, which helps medical centers diagnose diseases more efficiently. For instance, Bracco Imaging S.p.A. recently acquired SurgVision, for developing a real-time Fluorescence Image Guided Surgery platform. The platform corresponds to an innovative intra-operative optical technique, which uses an infrared camera and contrast agent approach. The technique is designed to aid surgeons in distinguishing tumors from healthy tissue.

Developers are generally used for image optimization in industries. Black and white developers such as methyl phenidone, hydroxymethyl-methyl-phenidone, and dimezone are used to attain maximum image clarity. Considering the increasing demand for developers from medical and other industries, manufacturing companies are continuously working on the development of organic color developers. Such eco-friendly developments in imaging chemicals can augment its demand among versatile industries. 

Market Insights

Increasing demand for improved imaging in medical centers for diagnosing diseases can drive the growth of the global imaging chemicals market. Accurate diagnoses through improved images can avoid costly treatments, which is likely to benefit patients. Vouching these benefits of imaging chemicals, manufacturing companies are focused on product development through organic compounds. Frequent product launches, agreements, and mergers are key strategies of these companies to gain a competitive advantage in the market. This constant research input from manufacturers will also widen the scope of this market in the forecast period (2017-2025), states Grand View Research, Inc. in a recent report. The market is expected to value USD 11.9 billion by 2025. 

Some of the prominent players in the market are Kao Corporation, Vivimed Labs Ltd., BASF, Dow Chemical Company, Clariant Chemical Company, and Becton Dickinson and Company.

To get free sample request at:

Monday, 4 December 2017

New Systems Enable Innovation in Clinical Trial Supplies and Design

A clinical trial supply chain is more than just logistics. As many biopharmaceutical firms are expanding their operations across the globe, various elements of the trial may experience differences based on local regulations and infrastructure. Planning and management of clinical trial supplies is a complex task. Various factors such as regulatory compliance, temperature sensitivity, and drug safety and security have a considerable impact on costs and timelines of a study. Due to this, sponsors and clinical research organizations (CROs) have started focusing on clinical trial supply management.

Agile IRT/RTSM System for Supply Managers

By way of products and services, the market comprises manufacturing, supply chain management, and storage and distribution. Supply chain management is considered to be the leading segment thanks to advancement in technology and need to control R&D costs.

In the latest Xtalks webinar, industry experts discussed the importance of Agile Interactive Response Technology/Randomization and Trial Supply Management (Agile IRT/RTSM) in clinical trials. These systems allow developments in clinical trial designs and supply chain management. As procedures become more intricate and trials become patient-centric, the implemented system for randomization and clinical trial supply is going to be extremely essential for a better clinical systems strategy. These systems offer flexibility and speed, which can support complex procedures that need quick changes.

Market Insights

According to findings of a research report by Grand View Research, Inc., the global clinical trial supplies market is expected to witness expansion at a strong CAGR of 7% during the forecast period (from 2017 to 2025). Rising number of clinical trials, along with increasing complexity in conducting these trials, is a major growth driver for the global market. In addition, rising number of biosimilar and biologics drugs in clinical trials is estimated to contribute toward global market expansion.

Some of the leading companies operating in the worldwide market for clinical trial supplies are Thermo Fischer Scientific; PAREXEL International Corp.; Biocair International Ltd.; Almac Group Ltd.; Catalent Pharma Solutions; and Sharp Packaging Services.

To get free sample report at:

Friday, 1 December 2017

New Anti-aging Therapy using Astaxanthin Promises Better Results

Astaxanthin is reddish, naturally occurring, and powerful carotenoid pigment found in particular marine plants as well as animals. Astaxanthin is present in its maximum natural concentration in wild Pacific sockeye salmon. It is also present in algae, krill, shrimp, red trout, lobsters, and crab. It is one of the best natural antioxidants. It helps fight various health problems such as fatigue, joint pain, vision issues, and skin-related issues. 

Other key functions include:

Protecting the nervous system and cells from oxidative damage

Supporting cardiovascular health

Supporting immune system

Supporting brain health

Breakthrough Anti-aging Therapy using Astaxanthin

Owing to its many benefits, astaxanthin finds application in aquaculture and animal feed, cosmetics, nutraceuticals, and others. Rising demand for anti-aging creams and products is likely to benefit the cosmetics industry as a key application segment.

The John A. Burns School of Medicine of the University of Hawaii and Cardax Inc., Honolulu-based life sciences company, recently announced the results of their study assessing the use of astaxanthin in anti-aging therapy. The astaxanthin compound CDX-085 by Cardax showed capacity to considerably enhance the expression of the gene FOX03, which has an important role in longevity.

Market Overview

According to findings of a report by Grand View Research, Inc., the worldwide astaxanthin market is estimated to showcase rapid growth during the forecast period (from 2017 to 2025), reaching a value of USD 2.57 billion by 2025. Increased awareness about various health benefits and potential uses of astaxanthin is expected to help market expansion.

In addition, due to growing geriatric population, demand for cosmetics such as antioxidant products and anti-aging creams to enhance aesthetic appeal have increased. This factor is anticipated to boost the growth of the market over the next few years.

JX Nippon Oil and Energy Corp; Heliae Development, LLC; BlueOcean NutraSciences, Inc.; Fuji Chemical Industry Co., Ltd.; EID-Parry (India) Ltd.; and Cyanotech Corp. are some of the prominent companies operating in the worldwide astaxanthin market. These major companies are implementing strategies such as using new production technologies to gain the top market position.

To get free sample report at: